SCHEMBL4073507

SCHEMBL4073507

N#Cc1ccccc1S(=O)(=O)c1ccc2cc(-c3ccc(F)cc3F)ccc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 4/20 0.44
HTR2C P28335 4/20 0.44
KCNH2 Q12809 2/20 0.44
HSD11B1 P28845 1/20 0.42
ALOX5AP P20292 6/20 0.41
FEN1 P39748 6/20 0.41
PTGES2 Q9H7Z7 1/20 0.40
DRD2 P14416 1/20 0.39
ABCC9 O60706 1/20 0.38
ABCC8 Q09428 1/20 0.38
KCNJ11 Q14654 1/20 0.38
KCNJ8 Q15842 1/20 0.38
TUBB4A P04350 1/20 0.38
TUBB P07437 1/20 0.38
TUBA3C P0DPH7 1/20 0.38
STAT3 P40763 1/20 0.38
TUBA1B P68363 1/20 0.38
TUBA4A P68366 1/20 0.38
TUBB4B P68371 1/20 0.38
TUBB3 Q13509 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4069576 0.87 HSD11B1 (0.46) HTR2AHTR2CKCNH2HSD11B1ABCC9
SCHEMBL4077131 0.81 HTR2A (0.42) HTR2AHTR2CKCNH2ALOX5APFEN1
SCHEMBL4069294 0.80 ABL1 (0.45) HTR2AHTR2CKCNH2TUBB4ATUBB
SCHEMBL4076311 0.79 HTR2A (0.59) HTR2AHTR2CKCNH2ALOX5APFEN1
SCHEMBL4072138 0.78 HTR2A (0.57) HTR2AHTR2CKCNH2ALOX5APFEN1
SCHEMBL4072974 0.78 HTR2A (0.57) HTR2AHTR2CKCNH2ALOX5APFEN1
SCHEMBL28541788 0.76 HSD11B1 (0.61) HTR2AHTR2CKCNH2HSD11B1ABCC9
SCHEMBL4069121 0.74 HSD11B1 (0.47) HTR2AHTR2CKCNH2HSD11B1ABCC9
SCHEMBL4070853 0.74 FDFT1 (0.41) ALOX5APFEN1PTGES2MEN1KMT2A
SCHEMBL3165210 0.74 HTR2A (0.67) HTR2AHTR2CKCNH2HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7592456-B2 Arylsulfonylnaphthalene derivatives as 5HT2A antagonists MERCK SHARP & DOHME LIMITED (GB) 2009-09-22 US claimed
US-20070281952-A1 Arylsulfonylnaphthalene Derivatives As 5Ht2a Antagonists MERCK SHARPE & DOHME LIMITED (GB) 2007-12-06 US claimed
US-7592456-B2 Arylsulfonylnaphthalene derivatives as 5HT2A antagonists MERCK SHARP & DOHME LIMITED (GB) 2009-09-22 US disclosed
EP-1824817-B1 ARYLSULFONYLNAPHTHALENE DERIVATIVES AS 5HT2A ANTAGONISTS MERCK SHARP & DOHME (GB) 2009-02-04 EP disclosed
US-20070281952-A1 Arylsulfonylnaphthalene Derivatives As 5Ht2a Antagonists MERCK SHARPE & DOHME LIMITED (GB) 2007-12-06 US disclosed
EP-1824817-A1 ARYLSULFONYLNAPHTHALENE DERIVATIVES AS 5HT2A ANTAGONISTS MERCK SHARP & DOHME LTD. (GB) 2007-08-29 EP disclosed
WO-2006059149-A1 ARYLSULFONYLNAPHTHALENE DERIVATIVES AS 5HT2A ANTAGONISTS MERCK SHARP & DOHME LIMITED (GB) 2006-06-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070281952-A1 Arylsulfonylnaphthalene Derivatives As 5Ht2a Antagonists HTR2A, HTR2C, HTR1A HTR2A 1/4885HTR2C 2/4885KCNH2 445/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.